InvestorsHub Logo
Followers 12
Posts 788
Boards Moderated 0
Alias Born 09/26/2018

Re: None

Friday, 11/05/2021 5:33:11 PM

Friday, November 05, 2021 5:33:11 PM

Post# of 426562
Imagine being presented with the following opportunity on 9/15/2018:

- You can buy AMRN shares at $4/share on 11/5/21
- Reduce-It is an absolute smashing success! Best CVD data since statins.
- ADCOMM occurs, but Vascepa gets 16-0 positive vote!
- FDA approves broad label in late 2019
- EU approves broad label in early 2021
- China broad CVD label likely coming in next 60 days.

That's how fucked the execution here has been. Pretty unreal.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News